Immunohistochemical localization of inhibin and activin subunits, activin receptors and Smads in ovarian endometriosis

International Journal of Molecular Medicine

Volumn 25, Issue 1, 2010, Pages 17-23

  Mabuchi, Yasushi ^a   Yamamoto, Mareo ^b   Minami, Sawako ^a   Umesaki, Naohiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b WAKAYAMA ROSAI HOSPITAL   (Japan)

Author keywords

Activin; Activin receptor; Endometriosis; Endometrium; Inhibin; Smad

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; ACTIVIN RECEPTOR 1A; ACTIVIN RECEPTOR 1B; ACTIVIN RECEPTOR 2A; ACTIVIN RECEPTOR 2B; INHIBIN; INHIBIN ALPHA; INHIBIN BETA A; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA IN SITU;

ACTIVIN RECEPTORS; ACTIVINS; ADULT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; MIDDLE AGED; OVARIAN NEOPLASMS; SMAD PROTEINS; YOUNG ADULT;

EID: 70549107730     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000308     Document Type: Article

References (34)

1. Gazvani R and Templeton A: Peritoneal environment and angiogenesis in the pathophysiology of endometriosis. Reproduction 123: 217-226, 2002.
2. Massague J: Transforming growth factor beta family. Annu Rev Cell Biol 6: 597-641, 1990.
3. Mason AJ, Hayflick JS, Ling N, et al: Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318: 659-663, 1985.
4. Lapolt PS and Hsueh AJW: Moleculer basis of inhibin production and action. Mol Cell Neurosci 2: 449-463, 1991.
5. Vale W, Rivier C, Hsueh A, et al: Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44: 1-34, 1988.
6. Nakao A, Imamura T, Souchelnytskyi S, et al: TGF-β receptor-mediated signaling through Smad2, Smad3, and Smad4. EMBO J 16: 5353-5362, 1997.
7. Whitman M: Smads and early developmental signaling by the TGF-β superfamily. Genes Dev 12: 2445-2462, 1998.
8. Yue J and Mulder KM: Requirement of RAS/MAPK pathway activation by transforming growth factor-β1 production in a Smad-dependent pathway. J Biol Chem 275: 30765-30773, 2000.
9. Yue J and Mulder KM: Transforming growth factor-β signal transduction in epithelial cells. Pharmacol Ther 91: 1-34, 2001.
10. Woodruff TK and Mather JP: Inhibin, activin and the female reproductive axis. Annu Rev Physiol 57: 219-244, 1995.
11. Risbridger GP, Schmitt JF and Robertson DM: Activin and inhibins in endocrine and other tumors. Endocr Rev 22: 836-858, 2001.
12. Attisano L and Tuen Lee-Hoeflich S: The Smads. Genome Biol 2: 3010.1-3010.8, 2001.
13. Shi Y, Hata A, Lo RS, Massague J and Pavletich NP: A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388: 87-93, 1997.
14. Massague J: TGF-β signal transduction. Annu Rev Biochem 67: 753-791, 1998.
15. Pangas SA and Woodruff TK: Activin signal transduction pathways. Trends Endocrinol Metab 11: 309-314, 2000.
16. Lewis KA, Gray PC, Blount AL, et al: Betaglycan binds inhibin and can mediate functional antagonism of activin signaling. Nature 404: 411-414, 2000.
17. Otani T, Minami S, Kokawa K, Shikone T, Yamoto M, Nakano R: Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 91: 685-692, 1998.
18. Luo X, Xu J and Chegini N: The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-β. J Clin Endocrinol Metab 88: 4967-4976, 2003.
19. American Fertility Society: Revised American Fertility Society classification of endometriosis. Fertil Steril 43: 351-352, 1985.
20. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH and Zhu L: Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78: 148-153, 2002.
21. McLaren J, Prentice A, Charnock-Jones DS and Smith SK: Vascular endothelial growth factor (VEGF) concentraions are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 11: 220-223, 1996.
22. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I and Ishimaru T: Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium. Fertil Steril 79: 173-181, 2003.
23. Osuga Y, Tsutsumi O, Okazaki R, et al: Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 14: 1611-1613, 1999.
24. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ and Bradley A: Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-9, 1992.
25. Shikone T, Matzuk MM, Perlas E, et al: Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p-53 deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol 8: 983-985, 1994.
26. Reis FM, Blasio AM, Florio P, Ambrosini G, Loberto CD and Petraglia F: Evidence for local production of inhibin A and activin A in patients with ovarian endometriosis. Fertil Steril 75: 367-373, 2001.
27. Florio P, Luisi S, Vigano P, et al: Healthy women and patients with endometriosis show high concentration of inhibin A, inhibin B, and activin A in peritoneal fluid throughout menstrual cycle. Hum Reprod 13: 2606-2611, 1998.
28. Cobellis L, Reis FM, Luisi S, et al: High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer. J Soc Gynecol Investig 11: 203-206, 2004.
29. Oosterlynck DJ, Meuleman C, Waer M and Koninckx PR: Transforming growth factor-β activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 83: 287-292, 1994.
30. Miyaki M and Kuroki T: Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 306: 799-804, 2003.
31. Hahn SA, Schutte M, Hoque AT, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-335, 1996.
32. Eppert K, Scherer SW, Ozcelik H, et al: MADR2 maps to 18q21 and encodes a TGF-β regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
33. Jeruss JS, Sturgis CD, Rademaker AW and Woodruff TK: Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res 63: 3783-3790, 2003.
34. Moustakas A and Heldin CH: Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584, 2005.